{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2019:7BK3NW5LEZBOBHZQ7H7SKSW2FT","short_pith_number":"pith:7BK3NW5L","canonical_record":{"source":{"id":"1906.10163","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-24T18:27:28Z","cross_cats_sorted":[],"title_canon_sha256":"26adf3c5396d0d9f6eac086a71e7a2f691e07b606b2ada312e58973318d06d46","abstract_canon_sha256":"9975ff60a877fcf75ffd0cdc3d70ae115fd1d8d698f5af6e10995d7458db4e61"},"schema_version":"1.0"},"canonical_sha256":"f855b6dbab2642e09f30f9ff254ada2cea7db42ce44c93b9e41c032cf983b670","source":{"kind":"arxiv","id":"1906.10163","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1906.10163","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"arxiv_version","alias_value":"1906.10163v1","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1906.10163","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"pith_short_12","alias_value":"7BK3NW5LEZBO","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_16","alias_value":"7BK3NW5LEZBOBHZQ","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_8","alias_value":"7BK3NW5L","created_at":"2026-05-18T12:33:12Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2019:7BK3NW5LEZBOBHZQ7H7SKSW2FT","target":"record","payload":{"canonical_record":{"source":{"id":"1906.10163","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-24T18:27:28Z","cross_cats_sorted":[],"title_canon_sha256":"26adf3c5396d0d9f6eac086a71e7a2f691e07b606b2ada312e58973318d06d46","abstract_canon_sha256":"9975ff60a877fcf75ffd0cdc3d70ae115fd1d8d698f5af6e10995d7458db4e61"},"schema_version":"1.0"},"canonical_sha256":"f855b6dbab2642e09f30f9ff254ada2cea7db42ce44c93b9e41c032cf983b670","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:42:32.067157Z","signature_b64":"lG9D9khS1LCdra4KcPlvIg8en13l55Ep1n1Us7gtNBgH1VZxcSMJAy8oi9H5KPTBn3VZZWy2Nh2elh9tes6UCg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"f855b6dbab2642e09f30f9ff254ada2cea7db42ce44c93b9e41c032cf983b670","last_reissued_at":"2026-05-17T23:42:32.066636Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:42:32.066636Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1906.10163","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:42:32Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"IWtWm7d9tBORnZ5Mgtz3fJPLjSnAhMgsQBk8pmGGq824kwJYOqv6jMaxtruVnq5L4xlMf33TqXkmsA7IBh3aAg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T16:32:28.252569Z"},"content_sha256":"2b1c0ec04e511b39462f846b9d0154c238b1ba15ba3d50ac47fe2cfe22c79c8b","schema_version":"1.0","event_id":"sha256:2b1c0ec04e511b39462f846b9d0154c238b1ba15ba3d50ac47fe2cfe22c79c8b"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2019:7BK3NW5LEZBOBHZQ7H7SKSW2FT","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Hansi Zhang, Jiang Bian, Neil Charness, Qian Li, Thomas J George Jr, William Hogan, Yi Guo, Zhe He","submitted_at":"2019-06-24T18:27:28Z","abstract_excerpt":"Existing trials had not taken enough consideration of their population representativeness, which can lower the effectiveness when the treatment is applied in real-world clinical practice. We analyzed the eligibility criteria of Bevacizumab colorectal cancer treatment trials, assessed their a priori generalizability, and examined how it affects patient outcomes when applied in real-world clinical settings. To do so, we extracted patient-level data from a large collection of electronic health records (EHRs) from the OneFlorida consortium. We built a zero-inflated negative binomial model using a "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1906.10163","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:42:32Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"8WXv+60cjTqAt9/mHZyxiSk9pZQFktuTFXBIEzAQg4PBBOHOmIDPBXibCnu1xBE0pDaa3zM0qqP5gLmbwVkvCw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T16:32:28.253277Z"},"content_sha256":"33d9b130ea0d66dfea4539915843e8d61a7b6470f6793871fbc9878563419de3","schema_version":"1.0","event_id":"sha256:33d9b130ea0d66dfea4539915843e8d61a7b6470f6793871fbc9878563419de3"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/bundle.json","state_url":"https://pith.science/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-26T16:32:28Z","links":{"resolver":"https://pith.science/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT","bundle":"https://pith.science/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/bundle.json","state":"https://pith.science/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/state.json","well_known_bundle":"https://pith.science/.well-known/pith/7BK3NW5LEZBOBHZQ7H7SKSW2FT/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:7BK3NW5LEZBOBHZQ7H7SKSW2FT","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"9975ff60a877fcf75ffd0cdc3d70ae115fd1d8d698f5af6e10995d7458db4e61","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-24T18:27:28Z","title_canon_sha256":"26adf3c5396d0d9f6eac086a71e7a2f691e07b606b2ada312e58973318d06d46"},"schema_version":"1.0","source":{"id":"1906.10163","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1906.10163","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"arxiv_version","alias_value":"1906.10163v1","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1906.10163","created_at":"2026-05-17T23:42:32Z"},{"alias_kind":"pith_short_12","alias_value":"7BK3NW5LEZBO","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_16","alias_value":"7BK3NW5LEZBOBHZQ","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_8","alias_value":"7BK3NW5L","created_at":"2026-05-18T12:33:12Z"}],"graph_snapshots":[{"event_id":"sha256:33d9b130ea0d66dfea4539915843e8d61a7b6470f6793871fbc9878563419de3","target":"graph","created_at":"2026-05-17T23:42:32Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Existing trials had not taken enough consideration of their population representativeness, which can lower the effectiveness when the treatment is applied in real-world clinical practice. We analyzed the eligibility criteria of Bevacizumab colorectal cancer treatment trials, assessed their a priori generalizability, and examined how it affects patient outcomes when applied in real-world clinical settings. To do so, we extracted patient-level data from a large collection of electronic health records (EHRs) from the OneFlorida consortium. We built a zero-inflated negative binomial model using a ","authors_text":"Hansi Zhang, Jiang Bian, Neil Charness, Qian Li, Thomas J George Jr, William Hogan, Yi Guo, Zhe He","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-24T18:27:28Z","title":"Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1906.10163","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:2b1c0ec04e511b39462f846b9d0154c238b1ba15ba3d50ac47fe2cfe22c79c8b","target":"record","created_at":"2026-05-17T23:42:32Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"9975ff60a877fcf75ffd0cdc3d70ae115fd1d8d698f5af6e10995d7458db4e61","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-24T18:27:28Z","title_canon_sha256":"26adf3c5396d0d9f6eac086a71e7a2f691e07b606b2ada312e58973318d06d46"},"schema_version":"1.0","source":{"id":"1906.10163","kind":"arxiv","version":1}},"canonical_sha256":"f855b6dbab2642e09f30f9ff254ada2cea7db42ce44c93b9e41c032cf983b670","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"f855b6dbab2642e09f30f9ff254ada2cea7db42ce44c93b9e41c032cf983b670","first_computed_at":"2026-05-17T23:42:32.066636Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:42:32.066636Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"lG9D9khS1LCdra4KcPlvIg8en13l55Ep1n1Us7gtNBgH1VZxcSMJAy8oi9H5KPTBn3VZZWy2Nh2elh9tes6UCg==","signature_status":"signed_v1","signed_at":"2026-05-17T23:42:32.067157Z","signed_message":"canonical_sha256_bytes"},"source_id":"1906.10163","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:2b1c0ec04e511b39462f846b9d0154c238b1ba15ba3d50ac47fe2cfe22c79c8b","sha256:33d9b130ea0d66dfea4539915843e8d61a7b6470f6793871fbc9878563419de3"],"state_sha256":"89733a972d53e2c12e37a53977f229530bfb1b72a155a47025bd78124a87714e"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"rEqC9W2tanyI17ftsjmG3KdRyvqGm6xKCDkdBZBFWoUiwdFf93sHejcYi2967Q8oZ1hK8Od4EktOKGekcwztBQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-26T16:32:28.256664Z","bundle_sha256":"a2acec91ee15b6d9890b4460425ff1f5a78f9403e0c134ae5a132b42bc0be3c5"}}